To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Part 1 - Healthy VolunteersPart 2 - Patients With Hypertension

Interventions

DRUG

LFF269

LFF269 capsules twice daily (b.i.d)

DRUG

Placebo to LFF269

Placebo LFF269 b.i.d for 10 days in healthy volunteers

Trial Locations (1)

Novartis Investigative Site, Miami